Matches in Wikidata for { <http://www.wikidata.org/entity/Q66076663> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q66076663 description "clinical trial" @default.
- Q66076663 description "ensayu clínicu" @default.
- Q66076663 description "klinisch onderzoek" @default.
- Q66076663 description "клінічне випробування" @default.
- Q66076663 name "A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)" @default.
- Q66076663 name "A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002" @default.
- Q66076663 type Item @default.
- Q66076663 label "A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)" @default.
- Q66076663 label "A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002" @default.
- Q66076663 prefLabel "A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)" @default.
- Q66076663 prefLabel "A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002" @default.
- Q66076663 P1050 Q66076663-E122031C-BC3C-4495-87F9-26804A4F0CA7 @default.
- Q66076663 P1132 Q66076663-DEDEE822-8C0E-4B07-AE31-5D8A65E23A81 @default.
- Q66076663 P1476 Q66076663-4DCA0E8E-F4E2-40AE-A0A0-0A1A69E13E15 @default.
- Q66076663 P2899 Q66076663-1C0FEDDB-0A93-4D2F-9AC5-42D8C8B0B843 @default.
- Q66076663 P3098 Q66076663-53A532CA-8F7F-4A06-970B-3B38889C1C0F @default.
- Q66076663 P31 Q66076663-3AC336CE-524A-4638-8288-0230150CBC7D @default.
- Q66076663 P580 Q66076663-FA5616B6-6C8E-47A0-B6E5-2D5158D18894 @default.
- Q66076663 P582 Q66076663-A19F1658-20C3-4E62-93B0-4C8330520FEE @default.
- Q66076663 P6099 Q66076663-ABDE1450-DD4E-4103-A3D8-E0033755E42F @default.
- Q66076663 P8363 Q66076663-47726F99-F673-41F4-8E52-F8DFB2975655 @default.
- Q66076663 P1050 Q170990 @default.
- Q66076663 P1132 "+145" @default.
- Q66076663 P1476 "A Phase 2 Single-Arm Open-Label Extension Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (1311.5)" @default.
- Q66076663 P2899 "+18" @default.
- Q66076663 P3098 "NCT02986373" @default.
- Q66076663 P31 Q30612 @default.
- Q66076663 P580 "2016-12-15T00:00:00Z" @default.
- Q66076663 P582 "2018-07-08T00:00:00Z" @default.
- Q66076663 P6099 Q42824440 @default.
- Q66076663 P8363 Q78089383 @default.